Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 30786188

Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2019 Feb 21
First author
Bardia A

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Cancer Discov. 2019 May;9(5):570. doi: 10.1158/2159-8290.CD-NB2019-034.
    note
    Source null
    related pmid
    30867160
    relationship
    Comment in
  2. citation
    N Engl J Med. 2019 Jun 13;380(24):2382. doi: 10.1056/NEJMc1903943.
    note
    Source null
    related pmid
    31189048
    relationship
    Comment in

Authors and identifiers

  1. name
    Bardia A
    type
    Author
  2. name
    Mayer IA
    type
    Author
  3. name
    Vahdat LT
    type
    Author
  4. name
    Tolaney SM
    type
    Author
  5. name
    Isakoff SJ
    type
    Author
  6. name
    Diamond JR
    type
    Author
  7. name
    O'Shaughnessy J
    type
    Author
  8. name
    Moroose RL
    type
    Author
  9. name
    Santin AD
    type
    Author
  10. name
    Abramson VG
    type
    Author
  11. name
    Shah NC
    type
    Author
  12. name
    Rugo HS
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Bardia A
    type
    Author
  2. name
    Mayer IA
    type
    Author
  3. name
    Vahdat LT
    type
    Author
  4. name
    Tolaney SM
    type
    Author
  5. name
    Isakoff SJ
    type
    Author
  6. name
    Diamond JR
    type
    Author
  7. name
    O'Shaughnessy J
    type
    Author
  8. name
    Moroose RL
    type
    Author
  9. name
    Santin AD
    type
    Author
  10. name
    Abramson VG
    type
    Author
  11. name
    Shah NC
    type
    Author
  12. name
    Rugo HS
    type
    Author
bibliography ids
  1. nci-bib-e114563be2c3f80bafe7bc44
book metadata
content sha256
cbfc11287550983a1af5d3dc2fd97581905c451ce8c37414f26f0bedb58fc7ed
document type
citation
dois
  1. 10.1056/NEJMoa1814213
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:30786188
immutable id
pubmed:30786188@cbfc11287550983a1af5d3dc2fd97581905c451ce8c37414f26f0bedb58fc7ed
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
8
name
The New England journal of medicine
nlm unique id
0255562
pages
741-751
volume
380
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Cancer Discov. 2019 May;9(5):570. doi: 10.1158/2159-8290.CD-NB2019-034.
    note
    Source null
    related pmid
    30867160
    relationship
    Comment in
  2. citation
    N Engl J Med. 2019 Jun 13;380(24):2382. doi: 10.1056/NEJMc1903943.
    note
    Source null
    related pmid
    31189048
    relationship
    Comment in
outcomes validated
false
pmid
30786188
provenance
batch id
e808962322f3afebc564
provider
NCBI PubMed ESummary
record sha256
076fdd9dfb86b610fd470750cdb56e9f8032946a7db2a7e8af1cb474817df73f
response sha256
3d610336ca8dae92b82cdb6b3ee6cab382eb509e0349b0c68c261b042b036561
retrieved at
2026-09-09T23:47:41.002093+00:00
publication date
display
2019 Feb 21
precision
day
year
2019
publication types
  1. Clinical Trial, Phase I
  2. Clinical Trial, Phase II
  3. Journal Article
  4. Multicenter Study
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/30786188/
title
Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer.

Preserved source evidence · Not medical advice